Reviva Pharmaceuticals Holdings Inc (RVPHW) — Financial Flexibility Index

Latest as of September 2025: -0.57x

Reviva Pharmaceuticals Holdings Inc (RVPHW) has a Financial Flexibility Index of -0.57x as of September 2025. Free cash flow of $-5.59 Million (operating CF $-5.59 Million minus capex $4.00) represents -1% of total liabilities ($9.78 Million). Check RVPHW asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Financial Flexibility Index

-0.57x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-5.59 Million
Operating CF − Capex

Total Liabilities

$9.78 Million
USD

Capital Expenditures

$4.00
USD

Reviva Pharmaceuticals Holdings Inc Financial Flexibility Index (2018–2024)

Historical Financial Flexibility Index trend for Reviva Pharmaceuticals Holdings Inc across 7 annual periods. See working capital position of Reviva Pharmaceuticals Holdings Inc to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Reviva Pharmaceuticals Holdings Inc (2018–2024)

Year-by-year free cash flow to debt coverage for Reviva Pharmaceuticals Holdings Inc. For the full company profile including market capitalisation, see RVPHW stock market capitalisation.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -2.28x $-33.54 Million $-33.54 Million $14.69 Million ▼ -45.0%
2023 -1.58x $-28.32 Million $-28.32 Million $17.98 Million ▲ +12.5%
2022 -1.80x $-18.96 Million $-18.96 Million $10.53 Million ▲ +54.1%
2021 -3.93x $-10.67 Million $-10.67 Million $2.72 Million ▼ -218.2%
2020 -1.23x $-4.07 Million $-4.07 Million $3.30 Million ▼ -3748.1%
2019 -0.03x $-218.44K $-218.44K $6.81 Million ▲ +81.8%
2018 -0.18x $-1.07 Million $-1.07 Million $6.09 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities